The inaugural ADPKD guideline from KDIGO provides updated recommendations on therapies to slow disease progression, including the use of tolvaptan. In January 2025, Kidney Disease: Improving ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn ...

a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn Monitoring System ...

(11) Booster doses of PPSV23 are recommended five years after the initial PPSV23 dose, particularly for patients aged 19-64 years, as per the Kidney Disease: Improving Global Outcomes (KDIGO) ...

CKD was diagnosed based on the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 guidelines. Exclusion criteria included participation in other trials, acute kidney injury, end-stage kidney ...

A groundbreaking study revealed that platelet distribution width (PDW) could be used as a useful non-invasive biomarker for ...

AKI was defined according to Kidney Disease Improving Global Outcomes (KDIGO) guidelines. Secondary outcomes were risk factors for AKI identified by logistic regression and prevalence of chronic ...

eGFR was calculated using the Japanese creatinine-based formula (JPN-Cre), and CKD stages were classified according to KDIGO guidelines (eGFR < 60 mL/min/1.73 m 2) (19). Categorical variables were ...